Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Evert

Showing results (201-210 of 228) with videos related to

Pageof 23
Sort By:
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
International Journal of Cancer|October 19, 2019
LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancerRaquel Blazquez, Eva Rietkötter, Britta Wenske, et al.
British Journal of Cancer|December 26, 2022
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer CentreAlexander Scheiter, Frederik Hierl, Florian Lüke, et al.
Cancers|October 27, 2022
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA ConsortiumFlorian Lüke, Florian Haller, Kirsten Utpatel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of GermanyMarkus Krebs, Florian Haller, Silvia Spörl, et al.
BMC Medicine|January 13, 2026
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Simon Mellin, Felix Keil, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.
The Lancet. Infectious Diseases|January 12, 2020
Zoonotic spillover infections with Borna disease virus 1 leading to fatal human encephalitis, 1999-2019: an epidemiological investigationHans Helmut Niller, Klemens Angstwurm, Dennis Rubbenstroth, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
Pageof 23

Showing results (201-210 of 228) with videos related to

Sort By:
Pageof 23
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
International Journal of Cancer|October 19, 2019
LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancerRaquel Blazquez, Eva Rietkötter, Britta Wenske, et al.
British Journal of Cancer|December 26, 2022
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer CentreAlexander Scheiter, Frederik Hierl, Florian Lüke, et al.
Cancers|October 27, 2022
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA ConsortiumFlorian Lüke, Florian Haller, Kirsten Utpatel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of GermanyMarkus Krebs, Florian Haller, Silvia Spörl, et al.
BMC Medicine|January 13, 2026
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Simon Mellin, Felix Keil, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.
The Lancet. Infectious Diseases|January 12, 2020
Zoonotic spillover infections with Borna disease virus 1 leading to fatal human encephalitis, 1999-2019: an epidemiological investigationHans Helmut Niller, Klemens Angstwurm, Dennis Rubbenstroth, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
Pageof 23